+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Dinoprostone vaginal insert versus intravenous oxytocin to reduce postpartum blood loss following vaginal or cesarean delivery



Dinoprostone vaginal insert versus intravenous oxytocin to reduce postpartum blood loss following vaginal or cesarean delivery



Clinical and Experimental Obstetrics and Gynecology 37(1): 53-55



To compare the impact of a dinoprostone vaginal insert and intravenous oxytocin in reducing blood loss of women undergoing vaginal or cesarean delivery. This study was conducted among term singleton pregnancies delivered vaginally or by elective cesarean section. In the vaginally delivered cases, active management of the third stage of labor was conducted. During cesarean delivery, 20 IU of intravenous oxytocin was administered. Women, who either delivered via the vaginal or abdominal route, were then randomly allocated to receive 10 mg vaginal dinoprostone insert for 12 hours (group I, n: 100) or intravenous oxytocin (group II, n: 100), respectively. Mean blood loss and need for additional uterotonics and postpartum hemoglobin and hematocrit levels at 24 and 36 hours after delivery did not differ between the two groups. Women allocated to the dinoprostone vaginal insert arm experienced more nausea and vomiting. Dinoprostone vaginal insert was as effective as intravenous oxytocin in the prevention of postpartum blood loss.

(PDF emailed within 1 workday: $29.90)

Accession: 052628450

Download citation: RISBibTeXText

PMID: 20420283


Related references

Oxytocin Versus Dinoprostone Vaginal Insert for Induction of Labor After Previous Cesarean Delivery: A Retrospective Comparative Study. Obstetric and Gynecologic Survey 66(11): 671-672, 2011

Misoprostol vaginal insert versus dinoprostone vaginal insert: A comparison of labour and delivery outcomes. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2018, 2018

Oxytocin versus dinoprostone vaginal insert for induction of labor after previous cesarean section: a retrospective comparative study. Journal of Perinatal Medicine 39(4): 397-402, 2011

Vaginal Dinoprostone Versus Intravenous Oxytocin for Labor Induction in Patients Not Responsive to a First Dose of Dinoprostone: A Randomized Prospective Study. Reproductive Sciences 23(6): 779-784, 2017

Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 109(1): 25-29, 2010

Double-balloon catheter results in higher rate of vaginal delivery within 24 h when compared with dinoprostone vaginal insert. Evidence-Based Medicine 18(4): 140-141, 2014

Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor induction. Journal of Maternal-Fetal and Neonatal Medicine 13(4): 254-259, 2003

Labor induction for premature rupture of membranes using vaginal misoprostol versus dinoprostone vaginal insert. American Journal of Perinatology 31(3): 181-186, 2014

Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. American Journal of Obstetrics and Gynecology 185(4): 878-882, 2001

Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial. Archives of Gynecology and Obstetrics 280(1): 19-24, 2008

Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial. Bmj 362: K3546, 2018

Intramuscular versus intravenous prophylactic oxytocin for postpartum hemorrhage after vaginal delivery: a randomized controlled study. Archives of Gynecology and Obstetrics 294(5): 911-916, 2016

Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial. Trials 18(1): 541, 2018

Reduction in resource use with the misoprostol vaginal insert vs the dinoprostone vaginal insert for labour induction: a model-based analysis from a United Kingdom healthcare perspective. Bmc Health Services Research 16: 49, 2016

Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial. Obstetrics and Gynecology 112(4): 801-812, 2008